SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBLVN.L Regulatory News (BLVN)

  • There is currently no data for BLVN

EPT Disclosure

19 Mar 2009 10:24

FORM 38.5(b)

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS

WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RI STATUS

BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

(Rule 38.5(b) of the Takeover Code)

1. KEY INFORMATION

Name of exempt principal trader ABN AMRO BANK N.V. London Branch (Subsidiary of RFS Holding N.V.)
Company dealt in Bowleven Plc
Class of relevant security to which the dealings being disclosed relate (Note 1) ORD GBP 0.10
Date of dealing 18 March 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

Long Short
Number (%) Number (%)
(1) Relevant securities 100,000 0.1150% 0 0%
(2) Derivatives (other than options) 0 0% 0 0%
(3) Options and agreements to purchase/sell 0 0% 0 0%
Total 100,000 0.1150% 0 0%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities 0 0% 0 0%
(2) Derivatives (other than options) 0 0% 0 0%
(3) Options and agreements to purchase/sell 0 0% 0 0%
Total 0 0% 0 0%

(c) Rights to subscribe (Note 2)

Class of relevant security: Details

3. DEALINGS (Note 3)

(a) Purchases and sales

Purchase/sale Number of securities Price per unit (Note 4)
Purchase

Sale

Sale

Sale

Sale

Sale

Total

20,000

732

12,468

1,400

5,400

250,000

270,000

1.0056 GBP

0.9850 GBP

1.0000 GBP

1.0100 GBP

1.0200 GBP

1.0500 GBP

(b) Derivatives transactions (other than options)

Product name, e.g. CFD Long/short (Note 5) Number of securities (Note 6) Price per unit (Note 4)

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 6) Exercise

price

Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 4) AUD

(ii) Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 4)

(d) Other dealings (including new securities) (Note 3)

Nature of transaction (Note 7) Details Price per unit (if applicable) (Note 4)

4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO

Date of disclosure 19 March 2009
Contact name F. Wyeth
Telephone number (020) 7678 0480
Name of offeree/offeror with which connected Bowleven Plc
Nature of connection (Note 9) Corporate Broker

Notes: The Notes on Form 38.5(b) can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

Copyright Business Wire 2009

Date   Source Headline
24th Jul 20157:00 amRNSBomono Drilling Update
1st Jun 20157:00 amRNSBomono Operational Update
22nd May 20158:23 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
19th May 20153:33 pmRNSHolding(s) in Company
5th May 20157:01 amRNSBoard Changes
26th Mar 20157:00 amRNSDirector/PDMR Shareholding
25th Mar 20157:00 amRNSInterim Results Announcement
17th Mar 20157:00 amRNSEtinde Farm-Out Completed $165m Cash Received
4th Mar 20157:00 amRNSGroup Operational Update
24th Feb 20157:00 amRNSEtinde Farm-Out Update
30th Jan 20157:00 amRNSEtinde Farm-Out Update
21st Jan 20157:00 amRNSBomono Operational Update
9th Jan 20154:23 pmRNSEtinde Farm-out Update
23rd Dec 20142:29 pmRNSGrant of 2014 Bowleven Long-Term Incentive Plan
23rd Dec 201412:39 pmRNSDirector's Interest
23rd Dec 20147:00 amRNSEtinde Permit Update
18th Dec 201412:39 pmRNSRESULT OF ANNUAL GENERAL MEETING
16th Dec 20144:12 pmRNSDirector's Interest
16th Dec 20147:00 amRNSLong Term Incentive Plan
9th Dec 20147:00 amRNSBomono Permit - Licence Extension Granted
9th Dec 20147:00 amRNSBomono Permit - Licence Extension Granted
1st Dec 20147:00 amRNSAppointment of Nominated Adviser & Joint Broker
24th Nov 20144:37 pmRNSAnnual Financial Report
18th Nov 20143:50 pmRNSHolding(s) in Company
12th Nov 20147:00 amRNSPreliminary Results Announcement
28th Oct 20142:31 pmRNSEtinde - Longstop Date Extension Confirmed
27th Oct 20147:00 amRNSEtinde Farm-out Update
30th Sep 20147:30 amRNSTotal Voting Rights
1st Sep 20145:28 pmRNSBlock Admission Six Monthly Return
26th Aug 20147:00 amRNSEtinde Farm-out to LUKOIL/NewAge - Update
4th Aug 20147:00 amRNSEtinde Exploitation Authorisation Awarded
1st Aug 201410:58 amRNSHolding(s) in Company
21st Jul 201412:47 pmRNSResult of General Meeting
15th Jul 20147:00 amRNSUpdate on Petrofac Strategic Alliance Agreement
30th Jun 20144:10 pmRNSPosting of Circular to Shareholders
27th Jun 201410:46 amRNSDirector/PDMR Shareholding
27th Jun 20147:00 amRNSBomono Permit
24th Jun 20147:00 amRNSEtinde Farm-out agreement signed
3rd Jun 20147:00 amRNSEtinde Exploitation Authorisation Update
2nd May 20143:24 pmRNSHolding(s) in Company
9th Apr 20149:00 amRNSBlock Admission Return
7th Apr 201411:15 amRNSHolding(s) in Company
2nd Apr 201410:37 amRNSHolding(s) in Company
31st Mar 20147:00 amRNSInterim Results Announcement
14th Mar 20143:40 pmRNSHolding(s) in Company
4th Mar 20145:15 pmRNSHolding(s) in Company
6th Feb 20147:00 amRNSEtinde Exploitation Authorisation Update
23rd Jan 20144:31 pmRNSHolding(s) in Company
13th Jan 20144:48 pmRNSDirector Share Awards
9th Jan 20143:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.